相关实验视频
Updated: Jul 12, 2025

08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
14.6K
在加纳农村地区剖腹产后的胎儿结果及其相关结果
Eugene Sackeya1,2, Martin Muonibe Beru1,3, Richard Nomo Angmortey1,3
1Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
PloS one
|October 31, 2023
概括
这项研究发现,加纳的剖腹产率很高,胎儿死亡率很高. 改善手术时间和婴儿复苏可以提高通过CS出生婴儿的结果.
科学领域:
- 产科和妇科 产科和妇科
- 公共卫生 公共卫生
- 新生儿护理 新生儿护理
背景情况:
- 剖腹产率的上升趋势需要定期评估,特别是在资源有限的环境中.
- 选择性CS越来越普遍,但有关胎儿结果的数据仍然有限.
- 这项研究通过检查加纳塔塔莱地区医院的CS后胎儿死亡率来解决这一差距.
研究的目的:
- 为了确定剖腹产 (CS) 后胎儿死亡率.
- 确定通过CS.出生的新生儿胎儿死亡率的决定因素.
- 提供证据,以改善加纳的孕产妇和新生儿结果.
主要方法:
- 一项回顾性横截面研究分析了从2019年到2021年的275个CS病例.
- 检查了医疗记录,检查了母亲和产科特征以及胎儿死亡率数据.
- 使用后勤回归和千平方测试来确定重要的风险因素.
主要成果:
- 在1667例分娩中,剖腹产率为16.5%.
- 在CS.后观察到每1000例出生的胎儿死亡率为76.4.
- 低的第五分钟外观,脉,笑容,活动和呼吸 (APGAR) 评分 (0-3) 显著增加胎儿死亡风险 (AOR=523.19).
结论:
- 该研究确定了高的CS率和显著的胎儿死亡率,超过了世卫组织的建议.
- 对CS的关键征兆包括以前的CS,头骨皮层不成比例和延迟分娩.
- 减少手术等待时间,早期CS诊断和改善新生儿复苏等干预措施对于更好的胎儿结果至关重要.
更多相关视频
14:40Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015
9.5K
05:46Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
10.0K
相关概念视频
Fetal Circulation
1.0K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.0K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K